Changeflow GovPing Healthcare European Patent EP4670679A3 for Mitral Valve Pr...
Routine Notice Added Final

European Patent EP4670679A3 for Mitral Valve Prosthesis

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Prosthetics (A61F)
Published March 18th, 2026
Detected March 23rd, 2026
Email

Summary

The European Patent Office has published patent EP4670679A3 for a two-stage platform for mitral valve replacement, developed by Majoro Cardiac Innovations, LLC. This patent describes a system for percutaneously deploying a mitral annular ring platform and a valved-stent prosthetic device, aiming to provide a consistent platform for various vendors.

What changed

The European Patent Office has published patent application EP4670679A3, titled 'Platforms for Mitral Valve Replacement,' filed by Majoro Cardiac Innovations, LLC. The patent details a two-stage deployment system for mitral valve prostheses, involving an annular ring platform and a valved-stent device. This approach is designed to offer a standardized platform for mitral valve prosthetics, potentially accommodating devices from multiple manufacturers.

This publication is primarily informational for medical device manufacturers and healthcare providers involved in cardiovascular prosthetics. While it does not impose new regulatory obligations or compliance deadlines, it signifies a development in medical technology that may influence future product design and market offerings. Companies in this sector should be aware of this patent as it relates to innovation in mitral valve replacement technology.

Source document (simplified)

← EPO Patent Bulletin

PLATFORMS FOR MITRAL VALVE REPLACEMENT

Search Report EP4670679A3 Kind: A3 Mar 18, 2026

Applicants

Majoro Cardiac Innovations, LLC

Inventors

GORMAN, Joseph, H., III, GORMAN, Robert, C., GILLESPIE, Matthew, J.

Abstract

A mitral valve prosthesis is percutaneously and/or transapically deployed in at least two stages. In a first stage, a mitral annular ring platform adapted for percutaneous delivery is delivered to and anchored in the mitral valve annulus. In the second stage, a valved-stent mitral valve prosthetic device adapted for percutaneously delivery is delivered to the mitral valve annulus for mounting in the mitral annular ring platform. This approach provides a consistent platform for accepting valved-stent mitral valve prosthetic devices from different vendors to be used.

IPC Classifications

A61F 2/24 20060101AFI20260206BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

PLATFORMS FOR MITRAL VALVE REPLACEMENT

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4670679A3

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Development
Geographic scope
European Union EU

Taxonomy

Primary area
Medical Devices
Operational domain
Product Development
Topics
Healthcare Technology Pharmaceuticals

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.